Discover
HRMY
Harmony Biosciences Holdings, Inc.
36.00
2 x 26.07
2 x 45.61
bid
ask
-
0.41
1.13%
2 @ 04:00 PM
35.75 -0.25 (0.69%)
| Ytd | -3.79% | |
| 1y | 12.39% |
35.46
day range
36.64
25.52
52 week range
40.87
| Open | 36.50 | Prev Close | 36.41 | Low | 35.46 | High | 36.64 | Mkt Cap | 2.08B |
| Vol | 736.68K | Avg Vol | 834.25K | EPS | 2.48 | P/E | 14.52 | Forward P/E | 6.05 |
| Beta | 0.97 | Short Ratio | 5.83 | Inst. Own | 103.63% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 32.35 | 200-d Avg | 32.30 | 1yr Est | 44.36 |
| Income Statement | |||
| Total Revenue | 215.39M | ||
| Revenues (USD) | 215.39M | ||
| Cost of Revenue | 44.51M | ||
| Gross Profit | 170.88M | ||
| Operating Expenses | 133.58M | ||
| Research and Development Expense | 69.38M | ||
| Selling, General and Administrative Expense | 64.20M | ||
| Operating Income | 37.29M | ||
| Interest Expense | 3.23M | ||
| Income Tax Expense | 7.20M | ||
| Net Income | 32.49M | ||
| Net Income Common Stock | 32.49M | ||
| Net Income Common Stock (USD) | 32.49M | ||
| Consolidated Income | 32.49M | ||
| Earnings per Basic Share | 0.56 | ||
| Earnings per Basic Share (USD) | 0.56 | ||
| Earnings per Diluted Share | 0.55 | ||
| Earning Before Interest & Taxes (EBIT) | 42.92M | ||
| Earning Before Interest & Taxes (USD) | 42.92M | ||
| Weighted Average Shares | 57.82M | ||
| Weighted Average Shares Diluted | 58.78M | ||
| Balance Sheet | |||
| Cash and Equivalents | 589.40M | ||
| Cash and Equivalents (USD) | 589.40M | ||
| Investments | 281.08M | ||
| Investments Current | 51.52M | ||
| Investments Non-Current | 229.56M | ||
| Trade and Non-Trade Receivables | 108.22M | ||
| Current Assets | 778.82M | ||
| Total Assets | 1.27B | ||
| Debt Current | 20.00M | ||
| Total Debt | 158.81M | ||
| Current Liabilities | 217.34M | ||
| Debt Non-Current | 138.81M | ||
| Total Liabilities | 361.48M | ||
| Accumulated Retained Earnings (Deficit) | 193.39M | ||
| Accumulated Other Comprehensive Income | -413.00K | ||
| Shareholders Equity | 910.35M | ||
| Shareholders Equity (USD) | 910.35M | ||
| Assets Non-Current | 493.01M | ||
| Total Debt (USD) | 158.81M | ||
| Goodwill and Intangible Assets | 83.46M | ||
| Inventory | 5.28M | ||
| Liabilities Non-Current | 144.14M | ||
| Trade and Non-Trade Payables | 28.60M | ||
| Tax Assets | 153.56M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.97M | ||
| Net Cash Flow from Financing | -7.22M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -163.10M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -32.00M | ||
| Issuance (Purchase) of Equity Shares | 347.00K | ||
| Issuance (Repayment) of Debt Securities | -5.00M | ||
| Net Cash Flow from Investing | -183.65M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -151.65M | ||
| Net Cash Flow from Operations | 27.76M | ||
| Share Based Compensation | 10.31M | ||